Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Tan, C. R. C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Shah, G. L.; Scordo, M.; Chung, D. J.; Landau, H. J.; Giralt, S.; Lesokhin, A. M.; Korde, N.; Lin, D.; Wu, B.; Fowler, J.; Fernandez, M.; Usmani, S. Z. |
| Abstract Title: | Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401762 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.7536 |
| Notes: | Meeting Abstract: 7536 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
